A detailed history of Two Sigma Securities, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Two Sigma Securities, LLC holds 4,086 shares of BMY stock, worth $236,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,086
Previous 386,500 98.94%
Holding current value
$236,007
Previous $16.1 Million 98.69%
% of portfolio
0.0%
Previous 0.2%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $12.9 Million - $16.8 Million
-324,673 Reduced 98.76%
4,086 $211,000
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $13 Million - $17.1 Million
323,458 Added 6101.83%
328,759 $13.7 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $5.07 Million - $5.75 Million
-105,672 Reduced 95.22%
5,301 $287,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $10.3 Million - $12.3 Million
-212,599 Reduced 65.7%
110,973 $5.69 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $15.1 Million - $16.9 Million
261,082 Added 417.8%
323,572 $18.8 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $3.04 Million - $3.37 Million
47,695 Added 322.37%
62,490 $4 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $648,426 - $735,462
9,868 Added 200.28%
14,795 $1.03 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $231,736 - $274,408
-3,384 Reduced 40.72%
4,927 $354,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $570 - $337,097
4,387 Added 111.8%
8,311 $591,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $372,467 - $410,217
-5,129 Reduced 56.66%
3,924 $302,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $303,895 - $364,397
4,943 Added 120.27%
9,053 $661,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $690,003 - $804,382
-12,866 Reduced 75.79%
4,110 $256,000
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $92,660 - $108,539
1,566 Added 10.16%
16,976 $1 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $299,211 - $325,840
4,833 Added 45.69%
15,410 $1.03 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $245,972 - $278,731
4,260 Added 67.44%
10,577 $656,000
Q2 2020

Sep 10, 2020

SELL
$54.82 - $64.09 $4.46 Million - $5.21 Million
-81,300 Reduced 92.79%
6,317 $371,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $745,223 - $871,239
13,594 Added 18.36%
87,617 $5.15 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $1.67 Million - $1.98 Million
38,990 Added 111.3%
74,023 $3.75 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $1.36 Million - $1.51 Million
30,589 Added 688.32%
35,033 $1.59 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $1.17 Million - $1.39 Million
-25,867 Reduced 85.34%
4,444 $212,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $4.76 Million - $5.37 Million
-86,302 Reduced 74.01%
30,311 $1.88 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $3.83 Million - $4.77 Million
75,795 Added 185.69%
116,613 $6.45 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $2.13 Million - $2.45 Million
35,555 Added 675.57%
40,818 $2.58 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $61,498 - $67,049
-1,026 Reduced 16.31%
5,263 $323,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $347,341 - $400,860
6,289
6,289 $401,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.